AbbVie Inc. (ABBV) is expected to report earnings on Friday, October 30, 2026, after the close. Estimated release time 12:00 ET. Consensus EPS estimate is $3.86.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-31 | FY2026 Q2 | $3.61 | $3.65 | +1.1% | $16.99B |
| 2026-05-08 | FY2026 Q1 | $2.59 | $2.65 | +2.3% | $15.00B |
| 2026-02-20 | FY2025 Q4 | $2.65 | $2.71 | +2.3% | $16.62B |
| 2025-11-04 | FY2025 Q3 | $1.77 | $1.86 | +5.1% | $15.78B |
| 2025-08-04 | FY2025 Q2 | $2.88 | $2.97 | +3.1% | $15.42B |
| 2025-05-09 | FY2025 Q1 | $2.38 | $2.46 | +3.4% | $13.34B |
| 2025-02-14 | FY2024 Q4 | $2.98 | $2.16 | -27.5% | $15.10B |
| 2024-11-04 | FY2024 Q3 | $2.92 | $3.00 | +2.7% | $14.46B |
ABBV has beaten consensus EPS in 7 of its last 8 reported quarters.
See ABBV on the live calendar →